Positivity yield of HIV index testing services from selected healthcare facilities in Ondo State, southwest Nigeria

Background: Index testing is a voluntary process whereby HIV seropositive clients are counselled and, after obtaining consent, their sexual and needle sharing partners are offered HIV testing services. Index testing has been associated with high HIV positivity yield. The aim of this study is to determine the positivity yield and identify factors influencing the yield from index testing strategy in selected healthcare facilities in Ondo State, southwest Nigeria. Methodology: Six public hospitals in Ondo State with the highest HIV clients currently on treatment were selected. Records of all clients newly diagnosed to be HIV positive at the selected facilities from June 2018 to September 2019, and who had an outcome for index testing services were reviewed. Data were collected using a chart abstraction template from the index testing registers. Information collected included age and gender of the index clients and their partners, method of referral and notification of partners, HIV test results of partners and linkage status of new HIVpositive partners. Data analyses were done using the Statistical Package for the Social Sciences (SPSS) software version 24.0. Chi-square was used to test association between variables at a significance level of p<0.01. Results: The records of a total of 904 index clients and their partners were reviewed with partner elicitation ratio of 1:1. The mean ages of index clients and their partners were 38.52±10.96 and 38.98±10.79 years respectively, and majority of the index clients (34.6%) and partners (35.5%) were in the 35-44 years age group. A total of 548 index clients were females (60.6%) while 528 of their partners were males (58.4%), indicating  predominantly heterosexual (96.4%) and few homosexual (lesbian) relationships (3.6%). One-fifth (20%) of partners tested positive for HIV andwere all (100%) linked to antiretroviral therapy (ART). The HIV positivity rate in partners of male index clients (26.9%) was significantly higher than in partners of female index clients (15.5%) (p<0.01). Partner referral method was mostly through assisted referral (56%) and most (82%) were contacted by the index clients through phone. Conclusion: Due to its high positivity yield, index testing is a veritable strategy to increase HIV case detection and linkage to ART. Hence, proper deployment of index testing will be critical to improving ART coverage and achieving epidemiological control. Keywords: HIV, client; partner; index testing; ART; southwest Nigeri

Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen

Mesenchymal stem/stromal cells (MSCs) are self-renewing and multipotent progenitors, which constitute the main cellular compartment of the bone marrow stroma. Because MSCs have an important role in the pathogenesis of multiple myeloma, it is essential to know if novel drugs target MSCs. Melflufen is a novel anticancer peptide-drug conjugate compound for patients with relapsed refractory multiple myeloma. Here, we studied the cytotoxicity of melflufen, melphalan and doxorubicin in healthy human bone marrow-derived MSCs (BMSCs) and how these drugs affect BMSC proliferation. We established co-cultures of BMSCs with MM.1S myeloma cells to see if BMSCs increase or decrease the cytotoxicity of melflufen, melphalan, bortezomib and doxorubicin. We evaluated how the drugs affect BMSC differentiation into adipocytes and osteoblasts and the BMSC-supported formation of vascular networks. Our results showed that BMSCs were more sensitive to melflufen than to melphalan. The cytotoxicity of melflufen in myeloma cells was not affected by the co-culture with BMSCs, as was the case for melphalan, bortezomib and doxorubicin. Adipogenesis, osteogenesis and BMSC-mediated angiogenesis were all affected by melflufen. Melphalan and doxorubicin affected BMSC differentiation in similar ways. The effects on adipogenesis and osteogenesis were not solely because of effects on proliferation, seen from the differential expression of differentiation markers normalized by cell number. Overall, our results indicate that melflufen has a significant impact on BMSCs, which could possibly affect therapy outcome.Peer reviewe

Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen

Mesenchymal stem/stromal cells (MSCs) are self-renewing and multipotent progenitors, which constitute the main cellular compartment of the bone marrow stroma. Because MSCs have an important role in the pathogenesis of multiple myeloma, it is essential to know if novel drugs target MSCs. Melflufen is a novel anticancer peptide–drug conjugate compound for patients with relapsed refractory multiple myeloma. Here, we studied the cytotoxicity of melflufen, melphalan and doxorubicin in healthy human bone marrow-derived MSCs (BMSCs) and how these drugs affect BMSC proliferation. We established co-cultures of BMSCs with MM.1S myeloma cells to see if BMSCs increase or decrease the cytotoxicity of melflufen, melphalan, bortezomib and doxorubicin. We evaluated how the drugs affect BMSC differentiation into adipocytes and osteoblasts and the BMSC-supported formation of vascular networks. Our results showed that BMSCs were more sensitive to melflufen than to melphalan. The cytotoxicity of melflufen in myeloma cells was not affected by the co-culture with BMSCs, as was the case for melphalan, bortezomib and doxorubicin. Adipogenesis, osteogenesis and BMSC-mediated angiogenesis were all affected by melflufen. Melphalan and doxorubicin affected BMSC differentiation in similar ways. The effects on adipogenesis and osteogenesis were not solely because of effects on proliferation, seen from the differential expression of differentiation markers normalized by cell number. Overall, our results indicate that melflufen has a significant impact on BMSCs, which could possibly affect therapy outcome

Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen

Mesenchymal stem/stromal cells (MSCs) are self-renewing and multipotent progenitors, which constitute the main cellular compartment of the bone marrow stroma. Because MSCs have an important role in the pathogenesis of multiple myeloma, it is essential to know if novel drugs target MSCs. Melflufen is a novel anticancer peptide–drug conjugate compound for patients with relapsed refractory multiple myeloma. Here, we studied the cytotoxicity of melflufen, melphalan and doxorubicin in healthy human bone marrow-derived MSCs (BMSCs) and how these drugs affect BMSC proliferation. We established co-cultures of BMSCs with MM.1S myeloma cells to see if BMSCs increase or decrease the cytotoxicity of melflufen, melphalan, bortezomib and doxorubicin. We evaluated how the drugs affect BMSC differentiation into adipocytes and osteoblasts and the BMSC-supported formation of vascular networks. Our results showed that BMSCs were more sensitive to melflufen than to melphalan. The cytotoxicity of melflufen in myeloma cells was not affected by the co-culture with BMSCs, as was the case for melphalan, bortezomib and doxorubicin. Adipogenesis, osteogenesis and BMSC-mediated angiogenesis were all affected by melflufen. Melphalan and doxorubicin affected BMSC differentiation in similar ways. The effects on adipogenesis and osteogenesis were not solely because of effects on proliferation, seen from the differential expression of differentiation markers normalized by cell number. Overall, our results indicate that melflufen has a significant impact on BMSCs, which could possibly affect therapy outcome

Phytochemistry And The Anti-Bacterial Properties Of The Leaf Extracts Of Napolenaea imperialis (Mkpodu)

Methods: Leaf of Napolenaea imperialis was chemically screened for the presence, tannins, flavonoids, alkaloids, saponins, reducing sugar, phenols, steroid, fats and oils. Result: The antimicrobial study of Napolenaea imperialis showed that the aqueous extract of this plant inhibited the growth of the test organisms in the order of klebsiella spp > Staphyoccus, aureus and Escherichia coli> Pseudomonas aeruginosa > Coliform, while the anti-microbial study of the ethanol extract of Napolenaea imperialis inhibited the growth of the test organisms in the order of klebsiella spp and Escherichia coli > Staphylococcus aureus > pseudomonas aeruginosa and Coliform. Conclusion: Its anti-microbial activities and the presence of some bioactive agents support its use in herbal medicine. Keywords: Anti bacterial properties, leafextrats, Napolenaea imperialisTropical Journal of Medical Research Vol. 12 (1) 2008: pp. 14-1

Brief Report: Parent–Adolescent Informant Discrepancies of Social Skill Importance and Social Skill Engagement for Higher-Functioning Adolescents with Autism Spectrum Disorder

Parent- and adolescent-report of social skill importance and social skill engagement on the Social Skills Rating System (Gresham and Elliott in The social skills rating system, American Guidance Service, Circle Pines, 1990) were assessed in higher-functioning adolescents with Autism Spectrum Disorder (ASD). Compared to parents, adolescents reported that social skills were less important. Additionally, adolescents reported that they engaged in social skills more frequently than parents reported them to be engaging in social skills. Parents, but not adolescents, reported a discrepancy between importance and engagement, such that the importance of social skills was rated higher than the frequency of adolescent engagement in social skills. These results suggest that social skills interventions for individuals with ASD may need to target awareness of social skill importance and accurate monitoring of social skill engagement